Peter M Uong, MD
Allergy/Immunology · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Uong’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Drugs they prescribed that Part D paid
$54,041
Pharmacies billed $54,041 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 270) in 2024. At or below the middle of the specialty; the typical student in an organized health care education/training program clinician is at 0%.
200 generic and 70 brand-name prescriptions · $54,041 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Spiriva Respimat | 12 | $9,939 | $828 |
| Wixela Inhub | 17 | $4,644 | $273 |
| Alvesco | 15 | $4,448 | $297 |
| Epinephrine | 14 | $1,704 | $122 |
| Fluticasone Propionate | 54 | $1,566 | $29 |
See all 9 drugs
| Spiriva Respimat | 12 | $9,939 | $828 |
| Wixela Inhub | 17 | $4,644 | $273 |
| Alvesco | 15 | $4,448 | $297 |
| Epinephrine | 14 | $1,704 | $122 |
| Fluticasone Propionate | 54 | $1,566 | $29 |
| Azelastine | 37 | $649 | $18 |
| Ipratropium | 20 | $424 | $21 |
| Montelukast | 35 | $386 | $11 |
| Albuterol Sulfate Hfa | 16 | $260 | $16 |
Year by year
| 2024 | 270 | 75 | 0% (0) | 26% | $54,041 |
| 2023 | 278 | 71 | 0% (0) | 25% | $45,674 |
| 2022 | 276 | 86 | 0% (0) | 39% | $58,349 |
| 2021 | 238 | 84 | 0% (0) | 34% | $39,316 |
| 2020 | 164 | 62 | 0% (0) | 58% | $28,514 |
| 2019 | 131 | 64 | 0% (0) | 36% | $17,058 |
| 2018 | 123 | 46 | 0% (0) | 37% | $10,000 |
| 2017 | 29 | 14 | 0% (0) | None | $1,813 |
| 2016 | 13 | None | 0% (0) | None | $1,274 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Spiriva Respimat | 13 | $10,878 | $837 |
| Alvesco | 21 | $4,946 | $236 |
| Wixela Inhub | 17 | $2,782 | $164 |
| Fluticasone Propionate | 51 | $953 | $19 |
| Ipratropium | 20 | $677 | $34 |
| Azelastine | 32 | $540 | $17 |
| Montelukast | 46 | $505 | $11 |
| Olopatadine | 13 | $263 | $20 |
2022: 9 drugs
| Spiriva Respimat | 11 | $8,794 | $799 |
| Symbicort | 13 | $6,897 | $531 |
| Alvesco | 29 | $5,960 | $206 |
| Wixela Inhub | 19 | $3,654 | $192 |
| Epinephrine | 13 | $1,606 | $124 |
| Fluticasone Propionate | 44 | $774 | $18 |
| Montelukast | 40 | $433 | $11 |
| Azelastine | 21 | $357 | $17 |
| Albuterol Sulfate Hfa | 21 | $349 | $17 |
2021: 9 drugs
| Advair Hfa | 12 | $11,963 | $997 |
| Spiriva Respimat | 14 | $10,996 | $785 |
| Alvesco | 19 | $4,204 | $221 |
| Wixela Inhub | 33 | $3,725 | $113 |
| Ipratropium | 24 | $874 | $36 |
| Fluticasone Propionate | 27 | $528 | $20 |
| Azelastine | 20 | $359 | $18 |
| Albuterol Sulfate Hfa | 15 | $279 | $19 |
| Montelukast | 25 | $275 | $11 |
2020: 5 drugs
| Advair Hfa | 17 | $11,683 | $687 |
| Advair Diskus | 31 | $7,194 | $232 |
| Alvesco | 22 | $3,562 | $162 |
| Fluticasone Propionate | 24 | $452 | $19 |
| Ipratropium | 13 | $450 | $35 |
2019: 6 drugs
| Advair Diskus | 15 | $3,386 | $226 |
| Ipratropium | 16 | $886 | $55 |
| Ventolin Hfa | 11 | $572 | $52 |
| Fluticasone Propionate | 18 | $318 | $18 |
| Azelastine | 12 | $314 | $26 |
| Montelukast | 16 | $177 | $11 |
2018: 4 drugs
| Ventolin Hfa | 12 | $532 | $44 |
| Fluticasone Propionate | 26 | $470 | $18 |
| Azelastine | 14 | $364 | $26 |
| Montelukast | 15 | $201 | $13 |
Money from drug and device companies
$350 in 2019
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $250 | 2 payments
|
| CSL Behring | Hizentra | $100 | 2 payments
|
See all 4 published payments
| CSL Behring | Honoraria · 2019-09-10 | Haegarda | $25 |
| GlaxoSmithKline | Meals · 2019-02-22 | Nucala | $125 |
| GlaxoSmithKline | Meals · 2019-02-22 | Nucala | $125 |
| CSL Behring | Meals · 2019-02-22 | Hizentra | $75 |
Professional record
- NPI
- 1912267014
- Trained
- Texas Tech University Health Science Center School of Medicine, 2012
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 1919 E Thomas Rd, Phoenix, AZ, 85016
- NPI first listed
- 2012-05-22
- NPI last updated
- 2021-12-16
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.